Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results.
Alpha Cognition will present new clinical and real-world findings on its Alzheimer’s drug ZUNVEYL at the ASCP Annual Meeting (Oct. 29—Nov. 1, 2026) and the NEI Fall Congress (Nov. 5—8, 2026). Analyses indicate ZUNVEYL use in long-term care settings was associated with favorable cognitive, functional, behavioral, and sl
Alpha Cognition Inc. announced that new clinical and real-world data on ZUNVEYL and acetylcholinesterase inhibitors will be presented at the ASCP Annual Meeting and NEI Fall Congress.
Takeda Pharmaceutical Co (NYSE: TAK ) released first-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. Access the full call at Summary Takeda Pharmace
Alpha Cognition reported about $6 million in net product revenue for Q2 2026, said it reduced full-year 2026 operating expense guidance to $50 million-$54 million, and cited 94% GAAP gross product margin.